3Mes·

My portfolio update Q4 '25 IZF 20.2%

Following the rebalancing of the S&P Quality Aristocrats last Friday, the following stocks were removed from or added to my two ETF indices (50% weighting):


New additions:

$QDEV (+0,96%): $NOVN (+1,91%) , $REL (+0,46%) , $ITX (+1,33%) , $LSEG (+0,52%) , $DB1 (+0,23%) and more


$QUS5 (+1,15%): $BKNG (+2,67%) , $MRK (+2,2%) , $CRM (+1,07%) , $UNP (-1%) , $COR (+0,86%) , $CAH (+1,38%) and more


Kicked out of both indices and therefore according to S&P no longer Quality Aristocrats are among others: $BATS (+0,78%) , $7974 (+4,83%) , $HD (+1,11%) , $LOW (+0,66%) , $HLT (+1,17%)


In addition, the allocation of all individual stocks in the indices was reduced again to max. 5 % was limited.


Thanks to the recent rally of $$HY9H (+1,37%) my current top 10 weighting (ETFs+shares) is as follows:


3.48% Alphabet

3.04% SK Hynix

3.04% Broadcom

2.93% Meta

2.75% Microsoft

2.71% Apple

2.71% NVIDIA

2.55% Taiwan Semiconductor

2.13% Mastercard

2.08% Visa


New portfolio key figures:

P/E: 27.1 (<30) 🟢

Forward P/E: 21.1 (<25) 🟢

P/Β: 11.5 (<5) 🔴

EV/FCF: 28.7 (<25) 🟡

ROE: 42% (>15%) 🟢

ROIC: 19% (>15%) 🟡

EPS growth for the next 5 years: 15% (>7%) 🟢

Sales growth for the next 5 years: 9% (>5%) 🟡


My internal rate of return is currently 20.19%

attachment
8
3 Commenti

immagine del profilo
Thank you for the information on reallocation.

At what intervals is the $QDEV reallocated by Standard and Poor's?

Greetings
🥪
1
Visualizza tutti 2 ulteriori risposte
Partecipa alla conversazione